Tadiran Group Ltd (TLV:TDRN)

Augmedix Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	44.81	51.69	39.13	120.84	129.47	329.54
Cash & Short-Term Investments	44.81	51.69	39.13	120.84	129.47	329.54
Cash Growth	55.09%	32.12%	-67.62%	-6.67%	-60.71%	264.00%
Accounts Receivable	501.04	531.13	429.16	395.94	301.47	196.29
Other Receivables	52.88	37.22	56.8	23.55	17.02	3.26
Receivables	553.92	568.42	486.05	419.61	318.6	199.6
Inventory	413.32	375.45	316.52	439.02	275.59	136.9
Other Current Assets	51.28	52.13	53.15	74.38	16.89	4.61
Total Current Assets	1,063	1,048	894.85	1,054	740.54	670.65
Property, Plant & Equipment	218.64	194.75	158.72	127.59	100.83	85.19
Long-Term Investments	21.61	19.38	18.92	21.81	20.98	-
Goodwill	205.01	197.29	258.18	242.41	36.65	2.55
Other Intangible Assets	143.78	143.72	137.96	148.02	38.84	13.4
Long-Term Accounts Receivable	-	0.05	3.66	4.53	0.75	-
Long-Term Deferred Tax Assets	13.68	15.14	15.89	15.77	14.07	9.44
Other Long-Term Assets	38.23	28.53	28.41	28.03	25.14	26.58
Total Assets	1,704	1,647	1,517	1,642	977.81	808.79
Accounts Payable	339.15	359.79	225.08	262.34	192.38	105.04
Accrued Expenses	-	32.69	26.59	24.34	20.92	16.48
Short-Term Debt	-	2.5	66.1	191.86	10.35	-
Current Portion of Long-Term Debt	47.93	35.85	34.02	35.84	35.24	34.06
Current Portion of Leases	21.96	15.95	13.09	15.62	9.38	7.34
Current Income Taxes Payable	-	4.28	0.73	23.3	6.67	5.57
Other Current Liabilities	202.01	128.96	161.36	239.57	94.94	85.23
Total Current Liabilities	611.04	580.02	526.97	792.87	369.87	253.71
Long-Term Debt	343.22	345.3	228.14	136.54	87.44	118.72
Long-Term Leases	62.64	47.15	21.3	29.18	18.89	9.2
Long-Term Unearned Revenue	-	29.2	24.39	23.55	22.06	22.38
Long-Term Deferred Tax Liabilities	33.95	34.97	33.61	39.87	12.65	4.09
Other Long-Term Liabilities	142.96	103.26	169.23	203.67	0.47	0.35
Total Liabilities	1,196	1,142	1,006	1,229	516.02	410.33
Common Stock	17.71	17.71	17.71	17.71	17.71	17.65
Additional Paid-In Capital	84.21	84.21	84.21	84.21	84.21	82.54
Retained Earnings	384.26	397.42	409.75	342.48	329.57	279.01
Comprehensive Income & Other	-2.63	-18.68	-1.5	-31.77	17.58	19.27
Total Common Equity	483.55	480.66	510.17	412.63	449.07	398.46
Minority Interest	24.71	23.48	0.04	-	12.72	-
Shareholders' Equity	508.26	504.14	510.21	412.63	461.79	398.46
Total Liabilities & Equity	1,704	1,647	1,517	1,642	977.81	808.79
Total Debt	475.75	446.74	362.66	409.04	161.31	169.31
Net Cash (Debt)	-430.94	-395.05	-323.53	-288.2	-31.84	160.23
Net Cash Growth	-	-	-	-	-	775.15%
Net Cash Per Share	-50.17	-46.01	-37.68	-33.57	-3.73	18.69
Filing Date Shares Outstanding	8.61	8.59	8.59	8.59	8.59	8.52
Total Common Shares Outstanding	8.61	8.59	8.59	8.59	8.59	8.52
Working Capital	452.29	467.68	367.87	260.97	370.67	416.94
Book Value Per Share	54.14	53.95	57.39	46.03	50.27	44.70
Tangible Book Value	134.76	139.65	114.03	22.2	373.58	382.52
Tangible Book Value Per Share	13.63	14.23	11.25	0.55	41.48	42.83
Buildings	-	66.8	64.88	64.15	62.87	62.15
Machinery	-	99.26	87.84	39.96	29.5	22.06
Leasehold Improvements	-	24.61	16.87	12.79	8.44	6.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.